← Open Payments lookup

GENESIS GOMEZ: Open Payments

NPI 1104488907 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,138 in 57 payments from 14 companies in 2025. Trend: 2023 $710 · 2024 $730 · 2025 $1,138

Food & beverage: $1,138
CompanyPaymentsAmount
ABBVIE INC.22$389
Phathom Pharmaceuticals, Inc.5$154
Madrigal Pharmaceuticals4$122
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$115
Takeda Pharmaceuticals U.S.A., Inc.4$77
VIVUS LLC4$63
Ardelyx, Inc.3$53
Gilead Sciences, Inc.2$48
GENZYME CORPORATION2$34
Novo Nordisk Inc1$20

Products named: CREON, VOQUEZNA, MAVYRET, REZDIFFRA, XIFAXAN, LINZESS, PANCREAZE, IBSRELA.

Industry payments across NY — which companies pay providers there.